180.12
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Seagen Inc | SGEN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 180.12 | 07:33:58 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 180.12 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 175.20 | 180.44 | 5.24 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 14 | 208 | 973,136 | 90.57 - 213.94 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 07:24:07 | 2 | $ 179.20 | USD |
Seagen Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 32.24B | 179.00M | 60.40M | $ 916.71M | $ 260.07M | -0.95 | 71.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Seagen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SGEN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 187.86 | 193.43 | 178.10 | 184.43 | 923,317 | -7.74 | -4.12% |
| 1 Month | 187.45 | 193.43 | 165.69 | 178.21 | 954,378 | -7.33 | -3.91% |
| 3 Months | 168.33 | 202.60 | 164.40 | 180.06 | 947,264 | 11.79 | 7.0% |
| 6 Months | 170.20 | 213.94 | 143.61 | 176.97 | 951,073 | 9.92 | 5.83% |
| 1 Year | 112.20 | 213.94 | 90.57 | 155.10 | 1,067,770 | 67.92 | 60.53% |
| 3 Years | 55.22 | 213.94 | 47.75 | 102.92 | 1,000,860 | 124.90 | 226.19% |
| 5 Years | 37.70 | 213.94 | 26.02 | 82.87 | 987,363 | 142.42 | 377.77% |
Seagen Description
| Seagen Inc is a biotech firm focused on developing antibody-drug conjugates. The company's lead product, Adcetris, has received approval for advanced front-line, relapsed/refractory and post-consolidation Hodgkin lymphoma, anaplastic large-cell lymphoma, and two other subtypes of cutaneous T-cell lymphoma. Other approved products include Padcev (bladder cancer) and Tukysa (breast cancer). The company has several other oncology programs in pivotal trials. Seagen also licenses its antibody-drug conjugate technology to a number of leading biotechnology and pharmaceutical companies. |
